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OBJECTIVES We examined the prevalence of defects in arrhythmia-related candidate genes among patients
with unexplained sudden cardiac death (SCD).
BACKGROUND Patients with unexplained sudden death may constitute up to 5% of overall SCD cases. For
such patients, systematic postmortem genetic analysis of archived tissue, using a candidate
gene approach, may identify etiologies of SCD.
METHODS We performed analysis of KCNQ1 (KVLQT1), KCNH2 (HERG), SCN5A, KCNE1, and
KCNE2 defects in a subgroup of 12 adult subjects with unexplained sudden death, derived
from a 13-year, 270-patient autopsy series of SCD. Archived, paraffin-embedded myocardial
tissue blocks obtained at the original postmortem examination were the source of deoxyri-
bonucleic acid for genetic analysis.
RESULTS Two patients were found to have the same HERG defect, a missense mutation in exon 7
(nucleotide change G1681A, coding effect A561T). The mutation was heterozygous in
Patient 1, but Patient 2 appeared to be homozygous for the defect. Patch-clamp recordings
showed that the A561T mutant channel expressed in human embryonic kidney cells failed to
generate HERG current. Western blot analysis implicated a trafficking defect in the protein,
resulting in loss of post-translational processing from the immature to the mature form of
HERG. No mutations were detected among the remaining four candidate genes.
CONCLUSIONS In this autopsy series, only 2 of 12 patients with unexplained sudden death were observed to
have a defect in HERG among five candidate genes tested. It is likely that elucidation of SCD
mechanisms in such patients will await the discovery of multiple, novel arrhythmia-causing
gene defects. (J Am Coll Cardiol 2004;43:1625–9) © 2004 by the American College of
Cardiology Foundationt
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satients with unexplained sudden death have no discernable
ardiac or extracardiac abnormalities that may have contrib-
ted to the terminal event. Among adults, such patients may
onstitute approximately 5% of cases in autopsy series of
udden cardiac death (SCD) (1). These subjects are usually
oung, and in up to 50% of cases, sudden death is the first
nd only clinical manifestation (2). Inherited primary elec-
rophysiologic disorders characterized by a structurally nor-
al heart, such as the long QT syndrome (LQTS) and
rugada syndrome, may account for an unknown propor-
ion of such patients (3–6). Except for a recent report on
udden infant death syndrome (7), there is limited informa-
ion on postmortem genetic analysis of unexplained sudden
eath in large series of patients with SCD.
We have previously reported a comprehensive postmor-
em phenotypic evaluation of a consecutive series of 270
dult cases of SCD, accrued at a cardiovascular registry over
3 years (2). In 12 patients (4.4%), sudden death occurred in
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nd the Doris Duke Foundation Innovation in Clinical Research Award. Dr. Zhou is
upported by grant HL68854 from the National Institutes of Health, Bethesda,
aryland, and the Howard Hughes Medical Institute Biomedical Research Support
rogram.dManuscript received October 8, 2003; accepted November 6, 2003.he presence of a structurally normal heart and in the
bsence of comorbidities associated with sudden death. We
herefore performed postmortem genetic analysis to inves-
igate the frequency of LQTS and Brugada syndrome gene
efects in this subgroup of 12 adult subjects with unex-
lained sudden death.
ETHODS
lassification and phenotyping from autopsy series.
etailed methods have been published previously (2). In
rief, the Jesse E. Edwards Cardiovascular Registry (St.
aul, Minnesota) is a repository of over 15,000 archived
earts from cases referred over approximately 45 years. The
resent autopsy series of SCD included all consecutively
eferred cases of sudden death in subjects age 20 years
uring 1984 to 1996 (n  270). All patients were residents
f the state of Minnesota, with the majority of cases (at least
7%) referred from the medical examiners of Hennepin,
amsey, and Anoka counties. All patients with noncardiac
onditions associated with sudden death were excluded.
utopsy reports and registry data of all patients were
eviewed to identify those with SCD and an apparently
ormal heart. Of the 14 patients identified (5%), only 12
ere included in the subgroup of patients with unexplained
udden death (2 had Wolff-Parkinson-White syndrome
iagnosed on the 12-lead electrocardiogram [ECG] [8]). Of
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Molecular Screening in Unexplained Sudden Death May 5, 2004:1625–9he 12 patients, one male patient was Native American and
ne female patient was Asian (Hmong descent). The
emaining 10 patients were Caucasian.
efinitions. Among witnessed deaths, SCD was defined
s unexpected death that occurred within 6 h of symptom
nset. Among unwitnessed deaths, patients were included if
hey were reported to have been observed symptom-free in
he previous 24 h.
enetic analysis of KCNQ1 and KCNH2 defects.
rchived, paraffin-embedded myocardial tissue blocks ob-
ained at the original postmortem examination were the
ource of deoxyribonucleic acid (DNA) for genetic analysis.
enomic DNA was extracted using the Qiagen DNeasy kit
Qiagen, Valencia, California). Segments of KCNQ1,
CNH2, SCN5A, KCNE1, and KCNE2 were amplified as
reviously described (9). Screening for KCNQ1 and
CNH2 defects was performed using single-stranded con-
ormational polymorphism (SSCP) (10,11). All segments
isplaying abnormal conformers were analyzed by auto-
ated sequencing (ABI 377, Applied Biosystems, Foster
ity, California). Defects in SCN5A, KCNE1, and KCNE2
ere directly analyzed using automated sequencing. For
atient 2, KCNH2 exon 7 was amplified and subcloned into
GemTeasy (Promega, Madison, Wisconsin), and multiple
ndependent clones were sequenced.
ite-directed mutagenesis and transfection. Complementary
NA of KCNH2 and the GeneEditor in vitro mutagenesis
ystem (Promega) were used. Human embryonic kidney
HEK) 293 cells were transiently transfected with wild-type
nd A561T mutant KCNH2/pcDNA3 constructs using a
ipofectamine method, as previously described (12).
atch-clamp recording and Western blot analysis.
hole-cell, patch-clamp recording and Western blotting
ere performed 48 h after transfection. Detailed conditions
nd buffer compositions for patch-clamp recordings have
een described previously (12). For Western blot analysis,
ell lysates were subjected to 7.5% sodium dodecyl sulfate-
olyacrylamide gel electrophoresis and transferred to nitro-
ellulose membranes. Membranes were incubated with an
nti-KCNH2 primary antibody, then secondary-conjugated
ntibody, and finally detected with an enhanced chemilu-
inescence detection kit (12).
ESULTS
linical profile of patients with KCNH2 defects. Of the
Abbreviations and Acronyms
ECG  electrocardiogram
HEK  human embryonic kidney
LQTS long QT syndrome
PCR  polymerase chain reaction
SCD  sudden cardiac death
SSCP  single-stranded conformational polymorphism2 patients tested, two had defects in KCNH2. Patient 1 eas a 32-year-old white female who suffered an unwit-
essed, unexpected sudden death while at home. There was
past medical history of seizure disorder, with two seizure
pisodes documented in seven years before death. There was
o known history of cardiac disease, and a 12-lead ECG
as not available in the medical records. Detailed postmor-
em examination revealed a structurally normal heart, and
bnormalities in other organs were limited to healed, focal
hronic pyelonephritis and a pleural adhesion of the right
ung. Her only medication was phenobarbital sodium for
reatment of seizure disorder. Findings on the postmortem
erum toxicology screen were limited to phenobarbital 13.6
g/ml (therapeutic range 20 to 50 g/ml). At the time of
eath, there was no known family history of sudden death or
ther cardiac disease.
Patient 2 was a 37-year-old white male who suffered a
itnessed, instantaneous, out-of-hospital SCD. Immedi-
tely before collapse, the patient had complained of chest
ain following moderate exercise (slow jogging for a 10-min
eriod). A 12-lead ECG for this patient was not available.
e was not taking any prescription or non-prescription
rugs. Detailed autopsy and cardiac pathologic examination
ere normal. The postmortem serum examination was also
egative. The family history was notable; the patient’s
other had also succumbed to sudden death at age 33 years.
enetic analysis of KCNH2 defects. In both patients,
SCP revealed abnormal conformers in KCNH2 exon 7.
fter automated sequencing, Patient 1 was found to have a
eterozygous missense mutation in exon 7, encoding the S5
egion of KCNH2 (nucleotide change G1681A, coding
igure 1. Partial deoxyribonucleic acid sequence of KCNH2 exon 7 for the
ild-type (A, single black peak) and mutant KCNH2 gene demonstrating
he same mutation in Patient 1 (heterozygous; B, two peaks: black and
reen) and Patient 2 (homozygous; C, single green peak). The latter was
onfirmed by PCR cloning and sequencing (D, single green peak).ffect A561T [9,13]) (Fig. 1B). The same defect was also
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May 5, 2004:1625–9 Molecular Screening in Unexplained Sudden Deathdentified in Patient 2, who was homozygous for the A561T
utation (Fig. 1C). Homozygosity in this patient was again
emonstrated by sequencing of multiple-cloned polymerase
hain reaction (PCR) amplicons, revealing a single mutant
llele (Fig. 1D).
dentification of benign polymorphisms. Among all 12
atients, only one such polymorphism was identified. A
0-year-old white female patient had a single base-pair
hange in SCN5A (nucleotide change G4650T, coding
ffect K1500N). This has previously been reported as a
onpathogenic variant with an estimated allele frequency of
.9% (14).
unctional analysis of the A561T mutation. Patch-clamp
ecordings of wild-type KCNH2 current showed voltage-
ependent activation, with inward rectification at more
ositive voltages. In contrast, the A561T mutant channel
id not express KCNH2 current in transfected HEK 293
ells (6 cells). The wild-type KCNH2 channel protein
xpressed two bands on Western blot analysis, a 135-kd
and (immature form of KCNH2) and a 155-kd band
mature form of KCNH2) (Fig. 2B) (12). In contrast,
561T expressed only the 135-kd band.
ISCUSSION
rom a 13-year autopsy series of 270 consecutive patients
ith SCD, 12 patients had SCD with a structurally normal
eart. Postmortem genetic analysis for defects in five LQTS
nd Brugada syndrome genes was performed on these 12
nrelated patients, using archived myocardium, and two
atients were found to have the identical mutation in exon
of KCNH2 (A561T). Patient 1 was heterozygous for this
utation, but Patient 2 appeared to be homozygous for the
efect. Our in vitro analysis of the KCNH2 A561T mutant
hannel revealed a post-translational defect that resulted in
bsence of the voltage-dependent delayed rectifier potas-
igure 2. Patch-clamp and Western blot analyses of the KCNH2 mutant
ith wild-type (WT) KCNH2 and A561T mutant, as indicated. The KCN
holding potential of 80 mV, and tail currents were recorded on repolar
ild-type KCNH2 and A561T mutant. The solid and dashed arrows indium current. Incidentally, both patients died several years pefore the gene defect for LQTS2 and the mechanistic link
ith KCNH2 mutations was to be discovered. Postmortem
olecular testing using a candidate gene-based approach
dentified gene defects in only 2 of 12 patients.
This specific missense mutation in KCNH2 (exon 7,
561T) has previously been reported in four kindreds with
hromosome 7-linked LQTS2, indicating a causal associa-
ion between this defect and the increased risk of polymor-
hic ventricular tachycardia and SCD (9,13). Among a
indred described in detail by Dausse et al. (13), there were
ight affected members spanning three generations. There
as a broad spectrum of clinical manifestations, which may
lso have been influenced by subsequent treatment in
symptomatic individuals carrying the mutation. Three
embers died at ages 65, 39, and 32 years, and a fourth had
borted sudden death (alive at age 40 years). Of the
emainder, one family member had a history of dizziness
age 41 years), and three were asymptomatic (age 15, 10,
nd 4 years). Furthermore, a finding on the 12-lead ECG
as found to be common to all affected members: in the
recordial leads, the T-wave was of low amplitude and had
characteristic biphasic pattern. Defects in KCNH2 (15)
ave also been identified as specific targets of drugs associ-
ted with SCD (11,16). As the serum toxicology in Patient
was positive for phenobarbital, in addition to the inherited
orm of LQTS, acquired LQTS remains a possibility
11,17). The observation that Patient 1 carried a diagnosis
f seizure disorder is also of interest when examined in the
ontext of concomitant LQTS. Polymorphic tachycardia
ith spontaneous resolution may manifest as seizure-like
ctivity in patients with LQTS (18). If Patient 1 did have
oth a seizure disorder and LQTS, this leaves open the
nteresting possibility that defects in KCNH2 may have
leiotropic phenotypes, as suggested by a recent study (19).
The gene KCNH2 encodes the alpha subunit of the
T. (A) Representative currents recorded from HEK 293 cells transfected
rrents were activated by depolarizing steps between 70 and 60 mV from
ns to 50 mV. (B) Western blot analysis of KCNH2 channel proteins of
immature and mature forms of KCNH2 protein, respectively.A561
H2 cu
izatiootassium channel conducting the rapidly activating, de-
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Molecular Screening in Unexplained Sudden Death May 5, 2004:1625–9ayed rectifier current (IKr) (15,16). The functional abnor-
alities of the A561T KCNH2 mutant ion channel have
ot been characterized. In the present study, patch-clamp
ecordings showed that A561T fails to generate KCNH2
urrent (Fig. 2A). In addition, Western blot analysis re-
ealed the defect at the protein level to be a lack of
ost-translational processing from the immature to the
ature form (Fig. 2B) (12). The wild-type KCNH2 channel
rotein is initially synthesized in the endoplasmic reticulum
s a core-glycosylated precursor form with a molecular mass
f 135 kd. Modification occurs in the Golgi apparatus, with
onversion to the mature form of the channel and a
olecular mass of 155 kd. Thus, this lack of processing is
ue to failure of the A561T mutant channel to reach the
lasma membrane (i.e., defective trafficking of KCNH2
rotein) (12). Defective protein trafficking has recently been
ecognized as an important mechanism for KCNH2 channel
ysfunction in LQTS2 (12,20). In fact, another LQTS2
utation involving the same codon (A561V) also causes a
rotein-trafficking defect (21). Because the residue A561 is
ocated in the S5 transmembrane domain and is highly
onserved in all members of the ether-a`-go-go family, this
esidue and/or domain may be a critical residue in normal
olding and trafficking of the KCNH2 channel.
All patients were referred from the same geographic area,
ith the majority of cases (87%) referred from the medical
xaminers in the Minneapolis-St. Paul tri-county region.
urthermore, the medical examiners referred all consecutive
ases of sudden death in a consistent fashion (2). In the
bsence of existing prospective, population-based evalua-
ions of sudden death, this methodology provides the
pportunity to examine a large series of consecutive SCD
ases. Although the possibility of gender bias exists, this
ould be unlikely, as the gender distribution in our overall
eries (approximately one-third were women) is consistent
ith previous autopsy series (22), cohort studies (23), and
nvestigations of survivors of SCD (24). Recognizing the
onstraints of this population, the incidence of gene defects
mplicated in the LQTS and Brugada syndromes among
atients with unexplained sudden death was 17% (2 of 12).
owever, we did not screen the present group of patients
or defects in the ryanodine receptor gene (RyR2), which
ave recently been implicated in the syndrome of cat-
cholaminergic polymorphic ventricular tachycardia (25–
7).
We used archived paraffin tissue blocks as a source of
enomic DNA, and the possibility of degradation of DNA
nd subsequent effects on genetic analysis exists. However,
his approach has been used successfully by others (28) and
ould provide the only means to perform such an analysis
rom a large autopsy series spanning 13 years. Homozygous
CNH2 mutations are rare and have not been previously
escribed for A561T. Two previous reports in the literature
29,30) reported on three individuals with novel homozy-
ous defects among two separate kindreds. Both kindreds
ad a separate mutation: L200fs/144 and L552S. Allffected individuals had a severe cardiac phenotype mani-
esting as torsade de pointes, 2:1 atrioventricular block, or
udden death, and no other phenotypic abnormalities. We
ere unable to use additional means to confirm the apparent
omozygosity of the mutation in Patient 2, such as South-
rn blotting (the mutation does not create/destroy a restric-
ion site) or familial segregation (other details of family
istory or familial samples could not be obtained). However,
equencing results were confirmed using multiple primers
or amplification, as well as multiple independent PCRs.
onclusions. In this 13-year autopsy series of 270 consec-
tive cases of SCD, there were 12 unrelated patients with
nexplained sudden death. Molecular screening using a
andidate gene approach identified gene defects in only 2 of
2 patients, both in KCNH2. The quest for novel,
rrhythmia-causing gene defects to elucidate mechanisms of
rrhythmogenesis in such patients will likely require larger,
rospective, population-based investigations.
cknowledgments
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